rather, they are physical evidence that the medication is successfully slowing down your digestion and recalibrating your satiety signals
Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H
Both Ozempic and Wegovy contain semaglutide as their active ingredient, but Wegovy is specifically FDA-approved for chronic weight management , utilizing higher doses than Ozempic
Clinical trials have shown that individuals on GLP-1 medications can achieve significant weight loss when paired with lifestyle changes such as a healthy diet and regular exercise
The FDA has signaled intent to take enforcement action against certain mass-marketed non-FDA-approved GLP-1 products and has drawn a clear distinction between mass-marketed compounded products and patient-specific compounding that may remain permissible in narrow circumstances
Patients typically report improved sleep quality within 23 weeks, with body composition changes emerging at 6090 days